2 undervalued ASX shares I think are set for a bull run

I think both of these ASX shares are primed to do well.

| More on:
man in old fashioned suit and hat looking through magnifying glass

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I'm a fan of both of the ASX shares I'm going to cover in this article. I think they're undervalued and could do well in 2024 and beyond.

ASX small-cap shares could still be an ideal hunting ground after various parts of the share market have rallied this year, or even in the last few weeks. Small businesses haven't seen that recovery in sentiment, for whatever reason.

But, just because a company hasn't performed well this year doesn't mean it's not going to in the future, whether that's regarding the share price and/or the financials. Here are two undervalued ASX shares I think are primed to perform in 2024.

Pacific Current Group Ltd (ASX: PAC)

Pacific Current is a business that takes stakes in investment managers from around the world, and helps them grow with expertise and some capital.

Some of its portfolio includes GQG Partners Inc (ASX: GQG), Victory Park, ROC Partners, Astarte and Pennybacker.

Fund managers are the types of businesses that can be very volatile – they can fall more than the market when the market goes down and rise more when the market goes up. That's because their funds under management (FUM) – a key input for earnings generation – will usually be impacted by whether share markets are going up or down in value.

Pacific Current's aggregate ownership-adjusted FUM has steadily grown over the last five years thanks to investment performance and FUM inflows.

With interest rates now (almost) at the peak, I think 2024 could see a recovery of investors contributing more money to the Pacific Current fund managers.

The estimate on Commsec suggests Pacific Current could generate earnings per share (EPS) of 70.2 cents and pay a dividend per share of 47.4 cents. This suggests the Pacific Current share price is valued at 12 times FY24's estimated earnings with an unfranked forward dividend yield of 5.6%. I think it's an attractive undervalued ASX share.

Reject Shop Ltd (ASX: TRS)

Reject Shop is a discount retailer that sells "high-quality private brands and sells products from Australia's most trusted brands including Cadbury, Tresemmé, Tontine, Nivea, Pepsi, Finish, Omo, Uncle Tobys" with a "single purpose in mind…to help all Australians save money." The company says it has around 380 locations.

I think the business is in a good position to help struggling households save money in the current environment – who doesn't like a bargain?

Reject Shop said at its annual general meeting that comparable store sales growth in the first 15 weeks "continues to be up on the prior corresponding period and is tracking" to the company's expectations. It's also working on growing its profit margin in FY24, despite inflationary pressures.

It's also expecting total sales growth in FY24 to be supported by new store openings – it's expecting to open 15 and close between eight to ten.

I think this is an undervalued ASX share – businesses with a low valuation that grow earnings can be attractive.

According to Commsec, it could generate 40.6 cents of EPS and pay a dividend per share of 22 cents in FY25. That puts the Reject Shop share price at 13 times FY25's estimated earnings with a potential grossed-up dividend yield of 6.1%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »